Man Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.85M | Buy |
135,425
+117,277
| +646% | +$5.06M | 0.01% | 846 |
|
|
2025
Q1 | $627K | Buy |
+18,148
| New | +$627K | ﹤0.01% | 1507 |
|
|
2024
Q3 | – | Sell |
-619,927
| Closed | -$15.7M | – | 1826 |
|
|
2024
Q2 | $15.7M | Buy |
+619,927
| New | +$15.7M | 0.04% | 489 |
|
|
2024
Q1 | – | Sell |
-7,100
| Closed | -$287K | – | 1979 |
|
|
2023
Q4 | $287K | Buy |
+7,100
| New | +$287K | ﹤0.01% | 1703 |
|
|
2023
Q1 | – | Sell |
-28,673
| Closed | -$218K | – | 2025 |
|
|
2022
Q4 | $218K | Sell |
28,673
-14,416
| -33% | -$110K | ﹤0.01% | 1734 |
|
|
2022
Q3 | $429K | Buy |
+43,089
| New | +$429K | ﹤0.01% | 1528 |
|
|
2022
Q2 | – | Sell |
-65,107
| Closed | -$661K | – | 1803 |
|
|
2022
Q1 | $661K | Buy |
+65,107
| New | +$661K | ﹤0.01% | 1483 |
|
|
2021
Q3 | – | Sell |
-4,552
| Closed | -$278K | – | 1819 |
|
|
2021
Q2 | $278K | Sell |
4,552
-55,146
| -92% | -$3.37M | ﹤0.01% | 1695 |
|
|
2021
Q1 | $3.68M | Sell |
59,698
-78,287
| -57% | -$4.82M | 0.02% | 840 |
|
|
2020
Q4 | $9.81M | Buy |
137,985
+13,963
| +11% | +$993K | 0.04% | 456 |
|
|
2020
Q3 | $4.65M | Buy |
124,022
+6,237
| +5% | +$234K | 0.02% | 847 |
|
|
2020
Q2 | $3.84M | Buy |
+117,785
| New | +$3.84M | 0.02% | 795 |
|